Post-Market Clinical Follow Up of Rotarex®S Catheter

CompletedOBSERVATIONAL
Enrollment

220

Participants

Timeline

Start Date

July 17, 2019

Primary Completion Date

October 26, 2022

Study Completion Date

October 26, 2022

Conditions
Peripheral Arterial Disease
Interventions
DEVICE

Atherectomy/Thrombectomy

Percutaneous transluminal removal of thrombotic, thromboembolic and atherothrombotic material from fresh, subacute and chronic occlusions of blood vessels in native blood vessels or vessels fitted with stents, stent grafts or native or artificial bypasses.

Trial Locations (13)

59759

Klinikum Hochsauerland GmbH, Arnsberg

Unknown

Angiocentrum Příbram, Příbram

East-Tallinn Central Hospital, Tallinn

CHU - Hôpital François-Mitterrand, Dijon

Universitäts-Herzzentrum Freiburg - Bad Krozingen, Bad Krozingen

Klinikum Friedrichshafen, Friedrichshafen

Universitätsklinik Leipzig, Leipzig

Bonifatius Hospital, Lingen

Universitätsklinikum Münster, Münster

Elblandklinikum Radebeul, Radebeul

Elblandklinikum Riesa, Riesa

"Kreiskrankenhaus Torgau Johann Kentmann", Torgau

Ospedale P. Pederzoli - Casa di Cura Privata Spa, Peschiera del Garda

All Listed Sponsors
lead

Straub Medical AG

INDUSTRY

NCT04010123 - Post-Market Clinical Follow Up of Rotarex®S Catheter | Biotech Hunter | Biotech Hunter